Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in ULTRAGENYX PHARMACEUTICAL IN
BNP PARIBAS FINANCIAL MARKETS holds 490,783 shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), worth $10.3M as of 2026-Q1. The position was decreased (-45.6% shares). RARE represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$10.3M
Current Shares
490,783
Total Value Change
+$7.5M
Total Shares Change
+423,311
Other major holders of RARE: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 490,783 |
-45.6% |
| $10.3M |
| 0.0% |
| $22.07 |
0 |
| 2025-Q4 | Increased | 903,050 | +57.6% | $20.8M | 0.0% | $22.78 | 41 |
| 2025-Q3 | Increased | 573,019 | +153.7% | $17.2M | 0.0% | $30.36 | 46 |
| 2025-Q2 | Increased | 225,826 | +27.7% | $8.2M | 0.0% | $36.52 | 34 |
| 2025-Q1 | Increased | 176,851 | +24.0% | $6.4M | 0.0% | $37.82 | 33 |
| 2024-Q4 | Increased | 142,628 | +394.7% | $6M | 0.0% | $42.27 | 44 |
| 2024-Q3 | Decreased | 28,831 | -57.3% | $1.6M | 0.0% | $54.43 | 0 |
| 2024-Q2 | Increased | 67,472 | +239.2% | $2.8M | 0.0% | $41.10 | 42 |